# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA2022933 | 12 | INH | < | 10 | % | ALA2024803 | % | ||||
2. | ALA2022933 | 12 | INH | = | 30.6 | % | ALA2026603 | % | Homo sapiens | |||
3. | ALA2022933 | 12 | Ratio IC50 | = | 126 | ALA2026604 | ||||||
4. | ALA2022933 | 12 | IC50 | = | 82 | uM | ALA2026605 | 4.09 | nM | Homo sapiens | ||
5. | ALA2022933 | 12 | IC50 | = | 0.65 | uM | ALA2026606 | 6.19 | nM | Homo sapiens | ||
6. | ALA2022933 | 12 | Ki | = | 65 | nM | ALA2026608 | 7.19 | nM | Electrophorus electricus | ||
7. | ALA2022933 | 12 | Ratio IC50 | = | 0.58 | ALA2026607 | ||||||
8. | ALA2022933 | 12 | IC50 | = | 356.9 | uM | ALA2026609 | nM | Rattus norvegicus | |||
9. | ALA2022933 | 12 | IC50 | = | 618.3 | uM | ALA2026610 | nM | Rattus norvegicus | |||
10. | ALA2022933 | 12 | Ratio IC50 | = | 1080 | ALA2024800 | ||||||
11. | ALA2022933 | 12 | IC50 | = | 27 | uM | ALA2024801 | 4.57 | nM | Equus caballus | ||
12. | ALA2022933 | 12 | IC50 | = | 0.025 | uM | ALA2024802 | 7.60 | nM | Electrophorus electricus | ||
13. | ALA2022933 | 12 | Inhibition | = | 24.32 | % | ALA4296184 | Average; N=2 | % | Staphylococcus aureus | ||
14. | ALA2022933 | 12 | Inhibition | = | 10.98 | % | ALA4296188 | Average; N=2 | % | Acinetobacter baumannii | ||
15. | ALA2022933 | 12 | Inhibition | = | 27.54 | % | ALA4296187 | Average; N=2 | % | Pseudomonas aeruginosa | ||
16. | ALA2022933 | 12 | Inhibition | = | 10.68 | % | ALA4296186 | Average; N=2 | % | Klebsiella pneumoniae | ||
17. | ALA2022933 | 12 | Inhibition | = | -2.2 | % | ALA4296185 | Average; N=2 | % | Escherichia coli | ||
18. | ALA2022933 | 12 | Inhibition | = | -92.31 | % | ALA4296190 | Average; N=2 | % | Cryptococcus neoformans | ||
19. | ALA2022933 | 12 | Inhibition | = | 1.92 | % | ALA4296189 | Average; N=2 | % | Candida albicans |